Brown R K, Duncan G, Hill D L
Cancer Treat Rep. 1980 Apr-May;64(4-5):643-8.
Following iv injection, melphalan was eliminated monophasically from rat serum (half-life = 0.87 hour) and monkey serum (half-life = 1.9 hours) and in rat bile (half-life = 2.4 hours) and monkey urine (half-life = 1.3 hours). In rat bile and monkey urine, 2% and 20% of the dose, respectively, was excreted in 12 hours as unchanged melphalan. At each time of tissue assay (0.5-4 hours after injection), rat spleen contained less melphalan than serum, liver, or kidneys. The kidneys and bile of monkeys contained more melphalan that serum, liver, or spleen. Only a small amount of radioactivity from labeled melphalan appeared in the feces of monkeys. Melphalan reached higher concentrations in implants of P388 and L1210 leukemia cells sensitive to melphalan than in cell lines resistant to this drug. Furthermore, the amounts of radioactivity bound to macromolecules of the sensitive tumors were higher.
静脉注射后,美法仑在大鼠血清(半衰期 = 0.87小时)和猴血清(半衰期 = 1.9小时)以及大鼠胆汁(半衰期 = 2.4小时)和猴尿(半衰期 = 1.3小时)中呈单相消除。在大鼠胆汁和猴尿中,分别有2%和20%的剂量在12小时内以未改变的美法仑形式排泄。在每次组织检测时(注射后0.5 - 4小时),大鼠脾脏中的美法仑含量低于血清、肝脏或肾脏。猴的肾脏和胆汁中的美法仑含量高于血清、肝脏或脾脏。标记美法仑产生的放射性仅少量出现在猴的粪便中。美法仑在对其敏感的P388和L1210白血病细胞植入物中的浓度高于对该药物耐药的细胞系。此外,与敏感肿瘤大分子结合的放射性量更高。